← Browse by Condition
Medical Condition

advanced solid tumors harboring kras g12c mutation

Total Trials
1
Recruiting Now
1
Trial Phases
Phase 1
NCT06659341 Phase 1
Recruiting

A Phase I Study of BAY3498264 Given Together With Sotorasib in Participants Who Have Advanced Solid Cancers With Specific Genetic Changes Called KRASG12C Mutation

Enrollment
104 pts
Location
Australia, Denmark, ...
Sponsor
Bayer
View Trial →